Cargando…

High-Density Lipoprotein – A Hero, a Mirage, or a Witness?

Negative relationship between plasma high-density lipoprotein (HDL) levels and risk of cardiovascular disease (CVD) is a firmly established medical fact, but attempts to reproduce protective properties of HDL by pharmacologically elevating HDL levels were mostly unsuccessful. This conundrum presents...

Descripción completa

Detalles Bibliográficos
Autor principal:	Sviridov, Dmitri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4668851/ https://www.ncbi.nlm.nih.gov/pubmed/26664860 http://dx.doi.org/10.3389/fcvm.2014.00009

Ejemplares similares

High Density Lipoproteins: Metabolism, Function, and Therapeutic Potential
por: Jomard, Anne, et al.
Publicado: (2020)

Association of the Monocyte–to–High-Density Lipoprotein Cholesterol Ratio With Diabetic Retinopathy
por: Tang, Xixiang, et al.
Publicado: (2021)

High Density Lipoprotein-Based Therapeutics: Novel Mechanism of Probucol in Foam Cells
por: Hafiane, Anouar, et al.
Publicado: (2022)

Global Burden Attributable to High Low-Density Lipoprotein-Cholesterol From 1990 to 2019
por: Du, Heyue, et al.
Publicado: (2022)

Achieved low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio predicts the pathophysiological evolution of lipid-rich plaques in acute coronary syndromes: an optical coherence tomography study
por: He, Luping, et al.
Publicado: (2023)

Relationship between high-density lipoprotein cholesterol levels and endothelial function in women: a cross-sectional study
por: Takaeko, Yuji, et al.
Publicado: (2020)

High Density Lipoprotein and Its Precursor Protein Apolipoprotein A1 as Potential Therapeutics to Prevent Anthracycline Associated Cardiotoxicity
por: Kluck, George E. G., et al.
Publicado: (2020)

Association between extremely high-density lipoprotein cholesterol and adverse cardiovascular outcomes: a systematic review and meta-analysis
por: Zhang, Guanwei, et al.
Publicado: (2023)

Endothelial Lipase Is Involved in Cold-Induced High-Density Lipoprotein Turnover and Reverse Cholesterol Transport in Mice
por: Schaltenberg, Nicola, et al.
Publicado: (2021)

Crosstalk between high-density lipoproteins and endothelial cells in health and disease: Insights into sex-dependent modulation
por: Dietrich, Elisa, et al.
Publicado: (2022)

The interaction between uric acid and high-density lipoprotein cholesterol on the prognosis of patients with acute myocardial infarction
por: Yang, Yu, et al.
Publicado: (2023)

Baseline Low-Density-Lipoprotein Cholesterol Modifies the Risk of All-Cause Death Associated With Elevated Lipoprotein(a) in Coronary Artery Disease Patients
por: Yao, Younan, et al.
Publicado: (2022)

Low-Density Lipoprotein Receptor-Related Protein-1 Signaling in Angiogenesis
por: Mao, Hua, et al.
Publicado: (2017)

Cumulative non-high-density lipoprotein cholesterol burden and risk of atherosclerotic cardiovascular disease: a prospective community-based study
por: Guan, Xu-Min, et al.
Publicado: (2023)

Dietary-Induced Elevations of Triglyceride-Rich Lipoproteins Promote Atherosclerosis in the Low-Density Lipoprotein Receptor Knockout Syrian Golden Hamster
por: Lin, Xiao, et al.
Publicado: (2021)

Prognostic Role of Neutrophil to High-Density Lipoprotein Cholesterol Ratio for All-Cause and Cardiovascular Mortality in the General Population
por: Jiang, Ming, et al.
Publicado: (2022)

Impact of low-density lipoprotein cholesterol and lipoprotein(a) on mid-term clinical outcomes following coronary artery bypass grafting: A secondary analysis of the DACAB trial
por: Yu, Qixiang, et al.
Publicado: (2023)

Efficacy and Safety of High-Density Lipoprotein/Apolipoprotein A1 Replacement Therapy in Humans and Mice With Atherosclerosis: A Systematic Review and Meta-Analysis
por: Abudukeremu, Ayiguli, et al.
Publicado: (2021)

The Dual Role of Low-Density Lipoprotein Receptor-Related Protein 1 in Atherosclerosis
por: Chen, Jiefang, et al.
Publicado: (2021)

Small, Dense Low-Density Lipoprotein-Cholesterol and Atherosclerosis: Relationship and Therapeutic Strategies
por: Jin, Xiao, et al.
Publicado: (2022)

Emerging Non-statin Treatment Options for Lowering Low-Density Lipoprotein Cholesterol
por: Bardolia, Chandni, et al.
Publicado: (2021)

Impact of low-density lipoprotein cholesterol on progression of aortic valve sclerosis and stenosis
por: Seo, Jeong Hun, et al.
Publicado: (2023)

The U-shaped association of non-high-density lipoprotein cholesterol with all-cause and cardiovascular mortality in general adult population
por: Huang, Yu, et al.
Publicado: (2023)

Low Density Lipoprotein Receptor-Related Protein-1 in Cardiac Inflammation and Infarct Healing
por: Potere, Nicola, et al.
Publicado: (2019)

Corrigendum: The dual role of low-density lipoprotein receptor–related protein 1 in atherosclerosis
por: Chen, Jiefang, et al.
Publicado: (2023)

Management of High Cardiovascular Risk in Diabetic Patients: Focus on Low Density Lipoprotein Cholesterol and Appropriate Drug Use in General Practice
por: Rottura, Michelangelo, et al.
Publicado: (2021)

High-Throughput Screening Identifies MicroRNAs Regulating Human PCSK9 and Hepatic Low-Density Lipoprotein Receptor Expression
por: van Solingen, Coen, et al.
Publicado: (2021)

The U-Shaped Association of Non-High-Density Lipoprotein Cholesterol Levels With All-Cause and Cardiovascular Mortality Among Patients With Hypertension
por: Cheng, Qi, et al.
Publicado: (2021)

Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: a systematic review
por: Ravnskov, Uffe, et al.
Publicado: (2016)

Comparison of a Machine Learning Method and Various Equations for Estimating Low-Density Lipoprotein Cholesterol in Korean Populations
por: Kwon, Yu-Jin, et al.
Publicado: (2022)

Spotlight on very-low-density lipoprotein as a driver of cardiometabolic disorders: Implications for disease progression and mechanistic insights
por: Lee, Hsiang-Chun, et al.
Publicado: (2022)

Short hydrocarbon stapled ApoC2-mimetic peptides activate lipoprotein lipase and lower plasma triglycerides in mice
por: Sviridov, Denis, et al.
Publicado: (2023)

Lymphocyte to High-Density Lipoprotein Ratio but Not Platelet to Lymphocyte Ratio Effectively Predicts Metabolic Syndrome Among Subjects From Rural China
por: Yu, Shasha, et al.
Publicado: (2021)

Relationship between the neutrophil to high-density lipoprotein cholesterol ratio and severity of coronary artery disease in patients with stable coronary artery disease
por: Gao, Jie, et al.
Publicado: (2022)

Low-Density Lipoprotein Cholesterol 4: The Notable Risk Factor of Coronary Artery Disease Development
por: Wu, Dongmei, et al.
Publicado: (2021)

Case Report: Are We Witnessing an Increase of Chronic Ascending Aortic Dissection as a Collateral Effect to the COVID-19 Pandemic?
por: Lyon, Arnaud, et al.
Publicado: (2021)

Association between low-density lipoprotein cholesterol level and mortality in patients with cardiogenic shock: a retrospective cohort study
por: Jin, Jiali, et al.
Publicado: (2021)

Low-density lipoprotein-cholesterol lowering effect of a nutraceutical regimen with or without ezetimibe in hypercholesterolaemic patients with statin intolerance
por: Ward, Natalie C., et al.
Publicado: (2022)

High-Density Lipoprotein Subfractions and Cholesterol Efflux Capacity Are Not Affected by Supervised Exercise but Are Associated with Baseline Interleukin-6 in Patients with Peripheral Artery Disease
por: Albaghdadi, Mazen S., et al.
Publicado: (2017)

Predictive Value of Non-high-Density Lipoprotein Cholesterol and Neutrophil-Lymphocyte Ratio for Coronary Artery Vulnerable Plaques in Type 2 Diabetes Mellitus
por: Huang, Xiyi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2kj3kusp41tpkirc9s1kr300qr